A Comparative Analysis of 5-Azacytidine- and Zebularine-Induced DNA Demethylation
Author(s) -
Patrick Griffin,
Chad E. Niederhuth,
Robert J. Schmitz
Publication year - 2016
Publication title -
g3 genes genomes genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.468
H-Index - 66
ISSN - 2160-1836
DOI - 10.1534/g3.116.030262
Subject(s) - dna methylation , methylated dna immunoprecipitation , biology , demethylating agent , dna demethylation , genetics , methylation , bisulfite sequencing , rna directed dna methylation , genome , illumina methylation assay , epigenomics , transposable element , transcriptome , dna , cpg site , methyltransferase , microbiology and biotechnology , gene , gene expression
The nonmethylable cytosine analogs, 5-azacytidine and zebularine, are widely used to inhibit DNA methyltransferase activity and reduce genomic DNA methylation. In this study, whole-genome bisulfite sequencing is used to construct maps of DNA methylation with single base pair resolution in Arabidopsis thaliana seedlings treated with each demethylating agent. We find that both inhibitor treatments result in nearly indistinguishable patterns of genome-wide DNA methylation and that 5-azacytidine had a slightly greater demethylating effect at higher concentrations across the genome. Transcriptome analyses revealed a substantial number of upregulated genes, with an overrepresentation of transposable element genes, in particular CACTA-like elements. This demonstrates that chemical demethylating agents have a disproportionately large effect on loci that are otherwise silenced by DNA methylation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom